Heart Failure Clinical Trial
Official title:
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum - Feasibility, Long-term Lead Stability and Safety
Cardiac pacing is the only effective treatment for symptomatic bradycardia. The right ventricular apex (RVA) has become the most frequently used ventricular pacing site. However, RVA pacing has been shown to cause left ventricular (LV) dyssynchrony wich can lead to LV dysfunction and development of heart failure. Recent studies in animals have demonstrated that pacing at the LV septum induces significantly less ventricular dyssynchrony than RVA pacing and is able to improve LV function to a similar degree as biventricular (BiV) pacing. In addition it was shown that a LV septum lead can be placed permanently by driving a lead with extended helix from the RV side through the inter-ventricular septum into the LV endocardial layer. This was shown to be a feasible and safe procedure and lead stability was shown during four months of follow-up in otherwise healthy and active canines. LV septum pacing may therefore be a good treatment alternative in patients with symptomatic bradycardia, as well as patients with an indication for cardiac resynchronization therapy (CRT). The purpose of this study is to translate the findings from preclinical studies to the clinical situation by investigating the feasibility, long-term lead stability and safety of LV septum pacing by transvenous approach through the inter-ventricular septum in patients.
Cardiac pacing is the only effective treatment for symptomatic bradycardia. After the
introduction of the implantable pacemaker (PM), the right ventricular apex (RVA) has become
the most frequently used ventricular pacing site. However, clinical studies have shown that
RVA pacing leads to left ventricular (LV) dyssynchrony, and on the long run to adverse
structural changes (remodeling), a higher risk of developing atrial fibrillation and heart
failure, and higher mortality.
Recognition of the adverse effects of RVA pacing has generated interest in alternative
ventricular pacing sites. Recent studies in animals have shown that pacing at the LV septum
induces significantly less ventricular dyssynchrony than RVA pacing. In addition it was
shown that a LV septum lead can be placed permanently by introducing a custom lead with
extended helix transvenously and, after positioning it against the RV septum, driving it
through the inter-ventricular septum into the LV endocardial layer. This was shown to be a
feasible and safe procedure and lead stability was shown during four months of follow-up in
otherwise healthy and active canines.
Animal studies have also shown that LV septum pacing is able to improve LV function to a
similar degree as simultaneous biventricular (BiV) pacing used in cardiac resynchronization
therapy (CRT). CRT was introduced to restore the abnormal ventricular activation and
contraction in patients with heart failure and intra-ventricular conduction delay. Large
clinical trials have shown that CRT improves LV systolic pump function, reverses structural
remodelling, improves quality of life and exercise tolerance, and decreases mortality.
Unfortunately, problems encountered during positioning and fixation of the LV pacing lead in
the coronary vein result in suboptimal or loss of CRT in at least a quarter of CRT
candidates and require re-operation in 7% during follow up.
The adverse effects of RVA pacing, the limitations of BiV pacing and the promising effects
of LV septum pacing in preclinical studies have led to the idea that LV septum pacing may be
a good treatment alternative in patients with symptomatic bradycardia, as well as patients
with an indication for CRT. In the latter category, CRT could then be performed using a
single ventricular pacing lead, thus limiting the number of lead implantations, and thereby
reducing complication rate and implantation costs as well as avoiding the difficult access
route through the coronary vein.
It is the aim of this study to translate the findings from preclinical studies to the
clinical situation by investigating the feasibility, long-term lead stability and safety of
LV septum pacing by transvenous approach through the inter-ventricular septum in patients
with a PM or CRT indication. The results may have a large impact on future pacing therapy.
The LV septum may become the universal pacing site, being preferred for anti-bradycardia
therapy, and being an equal alternative for BiV pacing, but easier to apply, less invasive
and more cost-effective.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|